We are live on ! Find out more
EDIT icon

Editas Medicine

194 hedge funds and large institutions have $149M invested in Editas Medicine in 2025 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 57 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

492% more call options, than puts

Call options by funds: $4.92M | Put options by funds: $830K

64% more capital invested

Capital invested by funds: $90.9M → $149M (+$58.4M)

4% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 23

0% more funds holding

Funds holding: 194194 (0)

1.47% less ownership

Funds ownership: 49.34%47.87% (-1.5%)

18% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 57

Holders
194
Holders Change
Holders Change %
0%
% of All Funds
2.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
47
Reduced
57
Closed
23
Calls
$4.92M
Puts
$830K
Net Calls
+$4.09M
Net Calls Change
+$2.85M
Name Holding Trade Value Shares
Change
Change in
Stake
Manulife (Manufacturers Life Insurance)
76
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$99.4K -$2.46K -880 -3%
Baird Financial Group
77
Baird Financial Group
Wisconsin
$99K -$918 -329 -1%
PFSRSONJ
78
Police & Firemen's Retirement System of New Jersey
New Jersey
$97K +$31.2K +11,178 +67%
SFI
79
Susquehanna Fundamental Investments
Pennsylvania
$95.9K
BNP Paribas Financial Markets
80
BNP Paribas Financial Markets
France
$94.3K +$18.9K +6,787 +33%
Rockefeller Capital Management
81
Rockefeller Capital Management
New York
$78.2K +$62.9K +22,537 New
Commonwealth Equity Services
82
Commonwealth Equity Services
Massachusetts
$77K -$3.67K -1,316 -6%
IAIM
83
International Assets Investment Management
Florida
$72K
RS
84
R Squared
Hong Kong
$71.6K
Focus Partners Wealth
85
Focus Partners Wealth
Massachusetts
$66.9K -$4.41K -1,580 -8%
HWA
86
HCR Wealth Advisors
California
$66.1K
HighTower Advisors
87
HighTower Advisors
Illinois
$64.2K -$6.21K -2,224 -11%
ProShare Advisors
88
ProShare Advisors
Maryland
$61.2K -$7.81K -2,799 -14%
EGM
89
Engineers Gate Manager
New York
$58.8K +$47.3K +16,947 New
VOYA Investment Management
90
VOYA Investment Management
Georgia
$55.8K -$24.9K -8,914 -36%
Cetera Investment Advisers
91
Cetera Investment Advisers
Illinois
$55.8K +$44.9K +16,088 New
CAPTRUST Financial Advisors
92
CAPTRUST Financial Advisors
North Carolina
$54.7K +$11.1K +3,972 +34%
CUAMC
93
China Universal Asset Management Company
China
$54.7K -$2.93K -1,051 -6%
Osaic Holdings
94
Osaic Holdings
Arizona
$53.5K +$1.03K +369 +2%
PFGIA
95
Patriot Financial Group Insurance Agency
Massachusetts
$52K
SG Americas Securities
96
SG Americas Securities
New York
$51K +$41.2K +14,754 New
Cerity Partners
97
Cerity Partners
New York
$49.8K -$1.93K -693 -5%
SEI Investments
98
SEI Investments
Pennsylvania
$46.2K +$37.2K +13,312 New
Universal-Beteiligungs- und Servicegesellschaft
99
Universal-Beteiligungs- und Servicegesellschaft
Germany
$45.5K
PNC Financial Services Group
100
PNC Financial Services Group
Pennsylvania
$44.1K

EDIT Hedge Fund Activity: Q3 2025 in Review

194 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2025, worth a combined $149M — up 64% from $90.9M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new EDIT positions and 23 closed out — a net gain of 1 holder — while 47 added to existing stakes and 57 trimmed.

The largest buyer was BlackRock, adding an estimated $3.35M. The largest seller was Millennium Management, cutting an estimated $4.3M.

  • 194 institutional investors held Editas Medicine (EDIT) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $149M of Editas Medicine stock for Q3 2025, up 64% quarter-over-quarter.
  • 24 funds opened new Editas Medicine positions in Q3 2025 and 23 closed out, a net change of +1 holder.
  • The largest Editas Medicine buyer in Q3 2025 was BlackRock, an estimated $3.35M added.
  • The largest Editas Medicine seller in Q3 2025 was Millennium Management, an estimated $4.3M sold.

Based on aggregated 13F filings for Q3 2025.